Carbohydrate and lipid metabolism in multiple sclerosis: Clinical implications for etiology, pathogenesis, diagnosis, prognosis, and therapy.
Multiple sclerosis (MS) is a complicated autoimmune disease characterized by inflammatory and demyelinating events in the central nervous system. The exact etiology and pathogenesis of MS have not been elucidated. However, a set of metabolic changes and their effects on immune cells and neural functions have been explained. This review highlights the contribution of carbohydrates and lipids metabolism to the etiology and pathogenesis of MS. Then, we have proposed a hypothetical relationship between such metabolic changes and the immune system in patients with MS. Finally, the potential clinical implications of these metabolic changes in diagnosis, prognosis, and discovering therapeutic targets have been discussed. It is concluded that research on the pathophysiological alterations of carbohydrate and lipid metabolism may be a potential strategy for paving the way toward MS treatment.
['Pashaei|Somayeh|S|', 'Mohammadi|Pantea|P|', 'Yarani|Reza|R|', 'Haghgoo|Seyyed Mortaza|SM|', 'Emami Aleagha|Mohammad Sajad|MS|']
D000818:Animals D050260:Carbohydrate Metabolism D006801:Humans D007107:Immune System D050356:Lipid Metabolism D009103:Multiple Sclerosis D011379:Prognosis
Multiple sclerosis Etiology Pathogenesis Diagnosis Therapy Carbohydrate/lipid metabolism